Aker BioMarine AS
OSE:AKBM.OL
43.6 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||||
Net Income
| -9 | 10 | -8.008 | -5.463 | -23.75 | -1.022 | -17.768 | -2.055 | 0.805 | -17.258 | 46.594 | -11.463 | -18.932 | 28.917 | -52.459 | -61.808 | -37.486 |
Depreciation & Amortization
| 50.2 | 49.4 | 51.082 | 48.247 | 36.947 | 22.861 | 0 | 16.397 | 15.527 | 18.018 | 0 | 19.702 | 9.885 | 11.227 | 10.872 | 7.887 | 13.598 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 23 | -38 | -52.691 | -79.439 | -15.432 | -13.111 | 0 | -2.198 | 1.266 | -9.922 | 0 | 0.179 | 2.01 | -8.335 | 0 | 0 | -1.838 |
Accounts Receivables
| 23 | -38 | -31.6 | -29.435 | -2.937 | -7.479 | 0 | -2.198 | 1.266 | -9.922 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | -23.667 | -20.545 | -19.336 | -7.506 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| 0 | 0 | 31.6 | 29.435 | 2.937 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 23 | 0 | -29.024 | -58.894 | 3.904 | -5.605 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non Cash Items
| -16.8 | -6.3 | 10.346 | -14.388 | 14.542 | -0.834 | 17.768 | 8.736 | 0.671 | -1.972 | -46.594 | -3.045 | 9.55 | -52.561 | 8.456 | 15.201 | -14.7 |
Operating Cash Flow
| 47.4 | 15.1 | 0.729 | -51.043 | 12.307 | 7.894 | 0 | 20.88 | 18.269 | -11.134 | 0 | 5.373 | 2.513 | -20.752 | -33.132 | -38.72 | -40.426 |
Investing Activities: | |||||||||||||||||
Investments In Property Plant And Equipment
| -49.3 | -46.1 | -81.107 | -23.709 | -126.916 | -64.512 | 0 | -10.788 | -17.422 | -12.042 | 0 | -43.524 | -36.356 | -2.892 | -13.633 | -50.192 | -37.67 |
Acquisitions Net
| 0 | -11.1 | -0.01 | -0.356 | -49.284 | -0.036 | 0 | 0 | 0 | 0 | 0 | -14.687 | -12.565 | -60.896 | 0 | 28.395 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.184 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28.066 | 0 | 0 | 0 |
Other Investing Activites
| 0.4 | 0.8 | 1.907 | 22.012 | 0.254 | 0.006 | 0 | -0.109 | -4.523 | -2.318 | 0 | 0 | 0 | 3.912 | 0 | 2.008 | 13.414 |
Investing Cash Flow
| -48.9 | -56.4 | -79.21 | -2.053 | -175.946 | -64.542 | 0 | -10.897 | -21.945 | -14.36 | 0 | -58.211 | -48.921 | -31.809 | -13.633 | -19.79 | -24.44 |
Financing Activities: | |||||||||||||||||
Debt Repayment
| -14.6 | -14.2 | -260.277 | -93.757 | -179.087 | -4.687 | 0 | -9.229 | -4.975 | -13.846 | 0 | -2.508 | -1.675 | -93.895 | -2.416 | -3.155 | -175.854 |
Common Stock Issued
| 0 | 0.2 | 0.019 | 224.178 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 43.882 | 0 | 149.178 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | -96.795 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 21.3 | 66.5 | 339.193 | 33.075 | -4.353 | 61.134 | 0 | 0 | 8.995 | 7.251 | 0 | 10.03 | 36.188 | 10.376 | 12.77 | 43.022 | 155.09 |
Financing Cash Flow
| 6.7 | 52.5 | 78.935 | 50.163 | 174.734 | 56.447 | 0 | -9.229 | 4.02 | 21.097 | 0 | 51.405 | 34.513 | 65.659 | 10.354 | 39.867 | -20.764 |
Other Information: | |||||||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0.001 | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 | -0.179 | 0 | -0.17 | -0.173 | 0.143 | -0.184 |
Net Change In Cash
| 5.2 | 11.2 | 0.454 | -2.932 | 11.095 | -0.2 | 0 | 0.754 | 0.344 | -4.397 | 0 | -1.433 | -11.895 | 12.928 | -36.584 | -18.5 | -85.814 |
Cash At End Of Period
| 27.5 | 22.3 | 11.132 | 10.678 | 13.61 | 2.515 | 3.506 | 3.506 | 2.752 | 2.408 | 0 | 0.896 | 2.178 | 14.288 | 1.381 | 31.55 | 64.131 |